Article Details

Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent

Retrieved on: 2021-05-06 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent. View article details on hiswai:

Excerpt

The year-over-year growth was driven by incremental contribution from the antibody cocktail, REGEN-COV (a cocktail of two monoclonal antibodies ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo